Article

Injection application accepted by FDA

The FDA is weighing the application by Amphastar Pharmaceuticals Inc. for a hyaluronidase injection 150 units/ml, 1ml.

Related Videos
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
© 2024 MJH Life Sciences

All rights reserved.